These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 29020837

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011.
    Mehta P, Antao V, Kaye W, Sanchez M, Williamson D, Bryan L, Muravov O, Horton K, Division of Toxicology and Human Health Sciences, Agency for Toxic Substances and Disease Registry, Atlanta, Georgia, Centers for Disease Control and Prevention (CDC).
    MMWR Suppl; 2014 Jul 25; 63(7):1-14. PubMed ID: 25054277
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Atlanta metropolitan area amyotrophic lateral sclerosis (ALS) surveillance: incidence and prevalence 2009-2011 and survival characteristics through 2015.
    Punjani R, Wagner L, Horton K, Kaye W.
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb 25; 21(1-2):123-130. PubMed ID: 31795746
    [Abstract] [Full Text] [Related]

  • 6. Feasibility of creating a National ALS Registry using administrative data in the United States.
    Kaye WE, Sanchez M, Wu J.
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep 25; 15(5-6):433-9. PubMed ID: 24597459
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of amyotrophic lateral sclerosis in the United States using established and novel methodologies, 2017.
    Mehta P, Raymond J, Punjani R, Han M, Larson T, Kaye W, Nelson LM, Topol B, Muravov O, Genson C, Horton DK.
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 Feb 25; 24(1-2):108-116. PubMed ID: 35422180
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of the Completeness of ALS Case Ascertainment in the US National ALS Registry: Application of the Capture-Recapture Method.
    Nelson LM, Topol B, Kaye W, Raymond J, Horton DK, Mehta P, Wagner T.
    Neuroepidemiology; 2022 Feb 25; 56(2):104-114. PubMed ID: 34929703
    [Abstract] [Full Text] [Related]

  • 10. Results of Florida's Amyotrophic Lateral Sclerosis Surveillance Project, 2009-2011.
    Freer C, Hylton T, Jordan HM, Kaye WE, Singh S, Huang Y.
    BMJ Open; 2015 Apr 21; 5(4):e007359. PubMed ID: 25900464
    [Abstract] [Full Text] [Related]

  • 11. Incidence of amyotrophic lateral sclerosis in the United States, 2014-2016.
    Mehta P, Raymond J, Punjani R, Larson T, Han M, Bove F, Horton DK.
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Aug 21; 23(5-6):378-382. PubMed ID: 35023792
    [Abstract] [Full Text] [Related]

  • 12. Incidence and geographical variation of amyotrophic lateral sclerosis (ALS) in Southern Germany--completeness of the ALS registry Swabia.
    Uenal H, Rosenbohm A, Kufeldt J, Weydt P, Goder K, Ludolph A, Rothenbacher D, Nagel G, ALS registry Study Group.
    PLoS One; 2014 Aug 21; 9(4):e93932. PubMed ID: 24722455
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of Amyotrophic Lateral Sclerosis - United States, 2015.
    Mehta P, Kaye W, Raymond J, Punjani R, Larson T, Cohen J, Muravov O, Horton K.
    MMWR Morb Mortal Wkly Rep; 2018 Nov 23; 67(46):1285-1289. PubMed ID: 30462626
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A brief report on juvenile amyotrophic lateral sclerosis cases in the United States National ALS Registry: 2010-2018.
    Raymond J, Berry J, Kasarskis EJ, Larson T, Horton DK, Mehta P.
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb 23; 25(1-2):211-213. PubMed ID: 37789566
    [Abstract] [Full Text] [Related]

  • 16. Comparing Amyotrophic lateral sclerosis (ALS) patient characteristics from the National ALS Registry and the Massachusetts ALS Registry, data through 2015.
    Raymond J, Punjani R, Larson T, Berry JD, Horton DK, Mehta P.
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 Aug 04; ():1-8. PubMed ID: 37539949
    [Abstract] [Full Text] [Related]

  • 17. Survival and epidemiology of amyotrophic lateral sclerosis (ALS) cases in the Chicago and Detroit metropolitan cohort: incident cases 2009-2011 and survival through 2018.
    Punjani R, Larson TC, Wagner L, Davis B, Horton DK, Kaye W.
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 May 04; 24(3-4):203-211. PubMed ID: 36200180
    [Abstract] [Full Text] [Related]

  • 18. Updated Prevalence and Demographic Characteristics for ALS Cases in Texas, 2009-2011.
    Rechtman L, Wagner L, Kaye W, Villanacci J.
    South Med J; 2015 Aug 04; 108(8):483-6. PubMed ID: 26280775
    [Abstract] [Full Text] [Related]

  • 19. A spatial analysis of amyotrophic lateral sclerosis (ALS) cases in the United States and their proximity to multidisciplinary ALS clinics, 2013.
    Horton DK, Graham S, Punjani R, Wilt G, Kaye W, Maginnis K, Webb L, Richman J, Bedlack R, Tessaro E, Mehta P.
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb 04; 19(1-2):126-133. PubMed ID: 29262737
    [Abstract] [Full Text] [Related]

  • 20. CDC Grand Rounds: National Amyotrophic Lateral Sclerosis (ALS) Registry Impact, Challenges, and Future Directions.
    Mehta P, Horton DK, Kasarskis EJ, Tessaro E, Eisenberg MS, Laird S, Iskander J.
    MMWR Morb Mortal Wkly Rep; 2017 Dec 22; 66(50):1379-1382. PubMed ID: 29267263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.